Apomorphine infusion does not impair cognitive action control in Parkinson's disease

被引：0
作者：
Duprez, J.
Houvenaghel, J. F.
Drapier, S.
Drapier, D.
Verin, M.
Sauleau, P.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
969
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
    Dafsari, Haidar S.
    Martinez-Martin, Pablo
    Rizos, Alexandra
    Trost, Maja
    dos Santos Ghilardi, Maria Gabriela
    Reddy, Prashanth
    Sauerbier, Anna
    Petry-Schmelzer, Jan Niklas
    Kramberger, Milica
    Borgemeester, Robbert W. K.
    Barbe, Michael T.
    Ashkan, Keyoumars
    Silverdale, Monty
    Evans, Julian
    Odin, Per
    Fonoff, Erich Talamoni
    Fink, Gereon R.
    Henriksen, Tove
    Ebersbach, Georg
    Pirtosek, Zvezdan
    Visser-Vandewalle, Veerle
    Antonini, Angelo
    Timmermann, Lars
    Chaudhuri, K. Ray
    Schrag, Anette
    Weintraub, Daniel
    Barone, Paolo
    Brooks, David J.
    Brown, Richard G.
    Jenner, Peter
    Jeon, B.
    Lyons, Kelly
    Pavese, Nicola
    Politis, Marios
    Postuma, Ronald B.
    Schapira, Anthony
    Stocchi, Fabrizio
    Tsuboi, Yoshio
    [J]. MOVEMENT DISORDERS, 2019, 34 (03) : 353 - 365
  • [22] Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome
    Reuter, I
    Ellis, CM
    Chaudhuri, KR
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1999, 100 (03): : 163 - 167
  • [23] Continuous apomorphine infusion: Efficacy in patients with advanced Parkinson's disease (PD)
    Zamarbide, I
    Alonso, F
    Rodriguez-Oroz, MC
    Aristu, A
    Obeso, JA
    [J]. MOVEMENT DISORDERS, 2004, 19 : S254 - S254
  • [24] Loss of Awareness after Continuous Apomorphine Infusion Withdrawal in Parkinson's Disease
    Oliveira, Vanessa
    Videira, Goncalo
    Mendes, Alexandre
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2020, 47 (04) : 576 - 577
  • [25] Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life
    Houvenaghel, Jean-Francois
    Drapier, Sophie
    Duprez, Joan
    Robert, Gabriel Hadrien
    Riou, Audrey
    Drapier, Dominique
    Sauleau, Paul
    Verin, Marc
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 395 : 113 - 118
  • [26] Effects of apomorphine on neuropsychiatric and cognitive function in patients with Parkinson's disease
    Postma, A. -G.
    Drent, M.
    van Laar, T.
    [J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S113 - S113
  • [27] Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease
    Clarke, Carl E.
    Worth, Paul
    Grosset, Donald
    Stewart, David
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 (10) : 728 - 741
  • [28] Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
    Peter Hagell
    Arja Höglund
    Carina Hellqvist
    Eva-Lena Johansson
    Berit Löwed
    Anne-Christine Sjöström
    Carina Karlberg
    Margareth Lundgren
    Nil Dizdar
    Anders Johansson
    Thomas Willows
    Johan Rådberg
    Filip Bergquist
    [J]. Journal of Neurology, 2020, 267 : 3411 - 3417
  • [29] Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease
    Hagell, Peter
    Hoglund, Arja
    Hellqvist, Carina
    Johansson, Eva-Lena
    Lowed, Berit
    Sjostrom, Anne-Christine
    Karlberg, Carina
    Lundgren, Margareth
    Dizdar, Nil
    Johansson, Anders
    Willows, Thomas
    Radberg, Johan
    Bergquist, Filip
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (11) : 3411 - 3417
  • [30] The control of an action in Parkinson’s disease
    M. Gentilucci
    Anna Negrotti
    [J]. Experimental Brain Research, 1999, 129 : 269 - 277
12345